Table 1.

List of treatment-related mutations acquired in each of the iPI3K-δ resistant tumors sequenced by WES

Mutations in iPI3K-δ–resistant tumors
Fourth round I-1Fourth round I-2Fourth round I-3Fourth round I-4Third round I-5Third round I-6
Lypd8 Pramel1 Sned1 Klhl9 Grb2 Cd44 
Hrh1 B230219D22Rik Ddhd1 Chpt1 Baz2b Slc39a12 
Mylk Gpc5 Pcdh18 Dnah10 Irak1bp1 Fat1 
Ddhd1 Srfbp1 Fat3 Enc1 Usp17lb Morc2b 
Elp3 Clpx Gdf10 Il2 Mpdz Myct1 
Rps12  Rps12 Grb2 Chrna7 Prkd1 
Gabra4  Clca4b Arhgef10l Xirp2 Ccp110 
Gc  Mboat1 Kdm6a  Klhl29 
Cyp19a1  Elp3 Xirp2  Osbpl1a 
Epb4.1l3  Siglec1 Dock5  Ptk2 
Plce1  Eml5 Ednra  Amy2b 
Klhl29  Anks4b Adcy9  Clpx 
Fat3  B4galnt3    
Mboat1  Ccdc106    
Crim1  Itga1    
Tubal3  Tmem132e    
Anks4b  Tubal3    
B4galnt3  Gc    
Siglec1  Hrh1    
Itga1  Plce1    
Pcdh18  Mylk    
Tshb  Lypd8    
Clca4b  Calcoco2    
Foxp2  4930407I10Rik    
Mutations in iPI3K-δ–resistant tumors
Fourth round I-1Fourth round I-2Fourth round I-3Fourth round I-4Third round I-5Third round I-6
Lypd8 Pramel1 Sned1 Klhl9 Grb2 Cd44 
Hrh1 B230219D22Rik Ddhd1 Chpt1 Baz2b Slc39a12 
Mylk Gpc5 Pcdh18 Dnah10 Irak1bp1 Fat1 
Ddhd1 Srfbp1 Fat3 Enc1 Usp17lb Morc2b 
Elp3 Clpx Gdf10 Il2 Mpdz Myct1 
Rps12  Rps12 Grb2 Chrna7 Prkd1 
Gabra4  Clca4b Arhgef10l Xirp2 Ccp110 
Gc  Mboat1 Kdm6a  Klhl29 
Cyp19a1  Elp3 Xirp2  Osbpl1a 
Epb4.1l3  Siglec1 Dock5  Ptk2 
Plce1  Eml5 Ednra  Amy2b 
Klhl29  Anks4b Adcy9  Clpx 
Fat3  B4galnt3    
Mboat1  Ccdc106    
Crim1  Itga1    
Tubal3  Tmem132e    
Anks4b  Tubal3    
B4galnt3  Gc    
Siglec1  Hrh1    
Itga1  Plce1    
Pcdh18  Mylk    
Tshb  Lypd8    
Clca4b  Calcoco2    
Foxp2  4930407I10Rik    

Mutations overlapping between the iPI3K-δ–resistant and -sensitive tumors are not included.

or Create an Account

Close Modal
Close Modal